Novartis signs $400M takeover deal with biotech firm

Novartis AG announced Wednesday that it will acquire Protez Pharmaceuticals, a biotech firm based in Malvern, Pa., for $400 million. The deal grants Novartis rights to PZ-601, an injectable antibiotic developed by Protez to fight potentially lethal drug-resistant infections, including those caused by MRSA and other superbugs.

View Full Article in:

American City Business Journals · Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Operating Officer
Health Plan of San Joaquin
French Camp , CA
Actuary
NTA Life
Addison, TX
Chief Information Officer
Meridian Health Plan
Detroit, MI
Vice President - Government Products
Health Alliance Plan
Detroit, MI
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA